News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Noemi Reguart: MARIPOSA (Ami + Lazer) show OS superiority over SoC in 1st line EGFRm NSCLC
Noemi Reguart/X
Mar 26, 2025, 13:32

Noemi Reguart: MARIPOSA (Ami + Lazer) show OS superiority over SoC in 1st line EGFRm NSCLC

Noemi Reguart, Medical Oncologist at Hospital Clinic Barcelona, shared a post on X:

“Osimertinib BEATEN!!

MARIPOSA (Ami + Lazer) shows significant OS (HR 0.75, p<0.005, 3yr 60% vs 51%) and landmark 3-yr icPFS improvement (36% vs 18%)—first combo to show OS superiority over SoC, extending OS beyond 3 years in first line EGFRm NSCLC.”

Noemi Reguart: MARIPOSA (Ami + Lazer) show OS superiority over SoC in 1st line EGFRm NSCLC

cancer fight against cancer Global fight against cancer Hospital Clinic Barcelona MARIPOSA MedOnc Noemi Reguart NSCLC OncoDaily Oncology osimertinib
Special Coverage
Blog
Mar 30, 2025, 19:05
New Council Recommendation on Vaccine-Preventable Cancers - European Cancer Organisation
Blog
Mar 30, 2025, 18:52
Cathy Eng: Happy Doctors Day to All My Colleagues
Blog
Mar 30, 2025, 18:31
Matthew Kurian: Happy Doctors’ Day to all the incredible physicians
Blog
Mar 30, 2025, 18:26
Indiana’s first mobile lung screening program is officially on the road - IU Simon Comprehensive Cancer Center
Blog
Mar 30, 2025, 18:14
Join the Richard and Alice Bucher Emerald Circle and help create a world without pediatric cancers - St. Baldrick's Foundation
Blog
Mar 30, 2025, 18:01
Philippe Spiess: Always an honor to deliver an update in the management of bladder cancer with Tom Flaig
Blog
Mar 30, 2025, 17:46
Thought-provoking trial on localized pancreatic cancer presented by Ethan Agritelley at SSO2025 - Duke Surgical Oncology
Blog
Mar 30, 2025, 17:44
Addressing Gaps in Awareness, Care, and Support for the Early-Age Onset Digestive Cancer Community - European Cancer Organisation
Blog
Mar 30, 2025, 17:34
Olga Kantor: Fantastic presentation by Monika Masanam on MIBC after NST at SSO2025
Blog
Mar 30, 2025, 17:19
Carlos Ayala-Navarro on the immune microenvironment in appendiceal cancers - Moffitt Cancer Center
Blog
Mar 30, 2025, 17:19
Roupen Odabashian: Comparing Research Compensation - Healthcare vs AI
Blog
Mar 30, 2025, 17:05
Julien Mazieres: Heterogeneity of resistance mechanisms should lead to a personalized strategy